![](/img/cover-not-exists.png)
Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response
Lior Katz, Javier P. Gisbert, Beth Manoogian, Kirk Lin, Casper Steenholdt, Gerassimos J. Mantzaris, Ashish Atreja, Yulia Ron, Arun Swaminath, Somal Shah, Ailsa Hart, Peter Laszlo Lakatos, Pierre EllulVolume:
aop
Year:
2012
Language:
english
Pages:
1
DOI:
10.1002/ibd.22902
File:
PDF, 903 KB
english, 2012